Medicaid Expansion and Availability of Opioid Medications in the Specialty Substance Use Disorder Treatment System.

ABSTRACT:

Objective

Research has examined the effect of Medicaid expansion on access to physicians with buprenorphine waivers, but less attention has been paid to Medicaid's impact on opioid use disorder medication availability within the specialty substance use disorder treatment system. To address this gap in the literature, this study examined the impact of Medicaid expansion on availability of opioid medications in specialty programs.

Methods

This study used data from the National Survey of the Substance Abuse Treatment Services (2002-2017), containing all known substance use disorder treatment programs in the United States, to examine the effect of Medicaid expansion on the availability of opioid use disorder medications by treatment program ownership type (publicly owned, privat

SUBMITTER: Abraham AJ 

PROVIDER: S-EPMC8262068 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature